Jochen Utikal

2001–2025 年に発表

200
論文数
40,590
被引用数
85
h 指数
191
i10 指数

被引用数

Jochen Utikal の年別被引用数1974 年: 被引用 1 件1987 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 3 件2001 年: 被引用 1 件2002 年: 被引用 3 件2003 年: 被引用 4 件2004 年: 被引用 2 件2005 年: 被引用 6 件2006 年: 被引用 15 件2007 年: 被引用 36 件2008 年: 被引用 109 件2009 年: 被引用 238 件2010 年: 被引用 218 件2011 年: 被引用 173 件2012 年: 被引用 172 件2013 年: 被引用 242 件2014 年: 被引用 244 件2015 年: 被引用 268 件2016 年: 被引用 386 件2017 年: 被引用 497 件2018 年: 被引用 623 件2019 年: 被引用 1,744 件2020 年: 被引用 2,199 件2021 年: 被引用 2,414 件2022 年: 被引用 2,015 件2023 年: 被引用 1,689 件2024 年: 被引用 2,566 件2025 年: 被引用 1,294 件2026 年: 被引用 83 件1975〜1986 年は被引用が無いため表示していません1988〜1990 年は被引用が無いため表示していません1993〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,138 件、この内訳の 24.2%中国: 引用元論文 3,020 件、この内訳の 14.3%ドイツ: 引用元論文 1,503 件、この内訳の 7.1%イタリア: 引用元論文 994 件、この内訳の 4.7%イギリス: 引用元論文 989 件、この内訳の 4.7%フランス: 引用元論文 734 件、この内訳の 3.5%オーストラリア: 引用元論文 660 件、この内訳の 3.1%スペイン: 引用元論文 601 件、この内訳の 2.8%オランダ: 引用元論文 588 件、この内訳の 2.8%カナダ: 引用元論文 534 件、この内訳の 2.5%日本: 引用元論文 528 件、この内訳の 2.5%インド: 引用元論文 507 件、この内訳の 2.4%
0%24.2%その他 25.4%

分野

  • Medicine47.7%
  • Biochemistry, Genetics and Molecular Biology30.3%
  • Immunology and Microbiology14.4%
  • Computer Science3.5%
  • Engineering1.4%
  • Neuroscience0.8%
  • その他1.9%

トピック

  • Cancer Immunotherapy and Biomarkers9.3%
  • Immunotherapy and Immune Responses6.4%
  • Cutaneous Melanoma Detection and Management4.6%
  • Melanoma and MAPK Pathways3.7%
  • Immune cells in cancer3.6%
  • CAR-T cell therapy research3.6%
  • その他68.8%

共著者

全論文

検索で開く
  1. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Diekmann, Janko Ciesla, Olga Waksmann, Alexandra-Kemmer Brück, Meike Witt, Martina Zillgen, Andrée Rothermel, Barbara Kasemann, David Langer, Stefanie Bolte, Mustafa Diken, Sebastian Kreiter, Romina Nemecek, Christoffer Gebhardt, Stephan Grabbe, Christoph Höller, Jochen Utikal, Christoph Huber, Carmen Loquai, Özlem Türeci - Nature 2017 被引用: 2,501

  2. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Verena Müller, Heidrun Mitzel-Rink, Matthias Miederer, Christoph Huber, Stephan Grabbe, Jochen Utikal, Andreas Pinter, Roland Kaufmann, Jessica C. Hassel, Carmen Loquai, Özlem Türeci - Nature 2020 被引用: 1,043

  3. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Science 2015 被引用: 2,995

  4. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Levi A. Garraway, Aviv Regev, Keith T. Flaherty, Annette Paschen, Eliezer M. Van Allen, Dirk Schadendorf - Nature Medicine 2019 被引用: 1,105

  5. Myeloid-derived suppressor cells in cancer and cancer therapy

    著者: , , , , - Nature Reviews Clinical Oncology 2024 被引用: 416

  6. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

    著者: , , , , , , - British Journal of Cancer 2018 被引用: 817

  7. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Danièle Ouellet, Anne‐Marie Martin, Ngocdiep T. Le, Kiran Patel, Keith T. Flaherty - New England Journal of Medicine 2014 被引用: 1,871

  8. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy

    著者: , , , , , , , - Cellular Immunology 2020 被引用: 312

  9. Explainable artificial intelligence in skin cancer recognition: A systematic review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Achim Hekler, Eva Krieghoff‐Henning, Titus J. Brinker - European Journal of Cancer 2022 被引用: 161

  10. Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jochen Utikal, Kamran Ghoreschi, Stefan Fröhling, Eva Krieghoff‐Henning, Alexander Salava, Alexander Thiem, Alexandris Dimitrios, Amr Mohammad Ammar, Ana Sanader Vučemilović, Andrea Miyuki Yoshimura, Andzelka Ilieva, Anja Gesierich, Antonia Reimer‐Taschenbrecker, Antonios G.A. Kolios, Arturs Kaļva, Arzu Ferhatosmanoğlu, Aude Beyens, Claudia Pföhler, Dilara Ilhan Erdil, Dobrila Jovanovic, Emöke Rácz, Falk G. Bechara, Federico Vaccaro, Florentia Dimitriou, Günel Rasulova, Hülya Cenk, Irem Yanatma, Isabel Kolm, Isabelle Hoorens, Iskra Petrovska Sheshova, Ivana Jocic, Jana Knuever, Janik Fleißner, Janis Thamm, Johan Dahlberg, Juan José Lluch‐Galcerá, Juan Sebastián Andreani Figueroa, Julia Holzgruber, Julia Welzel, Katerina Damevska, Kristine Elisabeth Mayer, Lara Valeska Maul, Laura Garzona-Navas, Laura Isabell Bley, Laurenz Schmitt, Lena Reipen, Lidia Shafik, Lidija Petrovska, Linda Golle, Luise Jopen, Magda Gogilidze, Maria Rosa Burg, Martha Alejandra Morales‐Sánchez, Martyna Sławińska, Miriam Mengoni, Miroslav Dragolov, N. Iglesias-Pena, Nina Booken, Nkechi Anne Enechukwu, Oana‐Diana Persa, Olumayowa Abimbola Oninla, Panagiota Theofilogiannakou, Paula Kage, Roque Rafael Oliveira Neto, Rosario Peralta, Rym Afiouni, Sandra Schuh, Saskia Schnabl-Scheu, Seçil Vural, Sharon Hudson ほか 24 名 - Nature Communications 2024 被引用: 151

  11. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodora Kanaki, Sarah Knispel, Katja Leonhard, Anna Martaki, Liliana Matei, Johanna Matull, Alexandra Olischewski, Maximilian Petri, Jan‐Malte Placke, Simon Raub, Katrin Salva, Swantje Schlott, Elsa Sody, Nadine Steingrube, Ingo Stoffels, Selma Ugurel, Anne Zaremba, Christoffer Gebhardt, Nina Booken, Maria Christolouka, Kristina Buder‐Bakhaya, Therezia Bokor‐Billmann, Alexander Enk, Patrick Gholam, Holger Hänßle, Martin Salzmann, Sarah K. Schäfer, Knut Schäkel, Timo Schank, Ann‐Sophie Bohne, Sophia Deffaa, Katharina Drerup, Friederike Egberts, Anna‐Sophie Erkens, Benjamin Ewald, Sandra Falkvoll, Sascha Gerdes, Viola Harde, Axel Hauschild, Marion Jost, Katja Kosova, Laetitia Messinger, Malte Metzner, Kirsten Morrison, Rogina Motamedi, Anja Pinczker, Anne Rosenthal, Natalie Scheller, Thomas Schwarz, Dora Stölzl, Federieke Thielking, Elena Tomaschewski, Ulrike Wehkamp, Michael Weichenthal, Oliver Wiedow, Claudia Bär, Sophia Bender-Säbelkampf, Marc Horbrügger, Ante Karoglan, Luise Kraas, Jörg Faulhaber, Cyrill Géraud, Ze Guo, Philipp Koch, Miriam Linke, Nolwenn Maurier, Verena Müller, Benjamin Thomas, Jochen Utikal, Ali Saeed M. Alamri ほか 34 名 - European Journal of Cancer 2019 被引用: 589

  12. Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konstantinos Liopyris, Mar Llamas‐Velasco, Josep Malvehy, Friedegund Meier, F. Max Müller, Alexander A. Navarini, Cristián Navarrete‐Dechent, Antonio Perasole, Gabriela Poch, Sebastián Podlipnik, Luis Requena, Veronica Rotemberg, Andrea Saggini, Omar P. Sangüeza, Carlos Santonja, Dirk Schadendorf, Bastian Schilling, Max Schlaak, Justin Gabriel Schlager, Mildred Sergon, Wiebke Sondermann, H. Peter Soyer, Hans Starz, Wilhelm Stolz, Esmeralda Vale, Wolfgang Weyers, Alexander Zink, Eva Krieghoff‐Henning, Jakob Nikolas Kather, Christof von Kalle, Daniel B. Lipka, Stefan Fröhling, Axel Hauschild, Harald Kittler, Titus J. Brinker - European Journal of Cancer 2021 被引用: 247

  13. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 2,141

  14. Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

    著者: , , , , , , , , , - Journal of Medical Internet Research 2018 被引用: 488

  15. Deep neural networks are superior to dermatologists in melanoma image classification

    著者: , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 410

  16. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey J. Legos, Fan Jin, Bijoyesh Mookerjee, Keith T. Flaherty - The Lancet 2015 被引用: 1,386

  17. Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

    著者: , , , , , , , - Frontiers in Immunology 2018 被引用: 551

  18. Superior skin cancer classification by the combination of human and artificial intelligence

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Salzmann, Sarah K. Schäfer, Knut Schäkel, Julia K. Winkler, Priscilla Wölbing, Hiba Asper, Ann‐Sophie Bohne, Victoria Brown, Bianca Burba, Sophia Deffaa, Cecilia Dietrich, Matthias Dietrich, Katharina Drerup, Friederike Egberts, Anna‐Sophie Erkens, Salim Greven, Viola Harde, Marion Jost, Merit Kaeding, Katharina Kosova, S. Lischner, Maria Maagk, Anna Laetitia Messinger, Malte Metzner, Rogina Motamedi, Ann-Christine Rosenthal, Ulrich Seidl, Jana Stemmermann, Kaspar Torz, Juliana Giraldo Velez, Jennifer Haiduk, Mareike Alter, Claudia Bär, Paul Bergenthal, Anne Gerlach, Christian Holtorf, Ante Karoglan, Sophie Kindermann, Luise Kraas, Moritz Felcht, Maria Rita Gaiser, Claus‐Detlev Klemke, Hjalmar Kurzen, Thomas Leibing, Verena Müller, Raphael Reinhard, Jochen Utikal, Franziska Winter, Carola Berking, Laurie Eicher, Daniela Hartmann, Markus V. Heppt, Katharina Kilian, Sebastian Krammer, Diana Lill, Anne‐Charlotte Niesert, Eva Oppel, Elke Sattler, Sonja Senner, Jens Wallmichrath, Hans Wolff, Anja Gesierich, Tina Giner, Valerie Glutsch, Andreas Kerstan, Dagmar Presser, Philipp Schrüfer, Patrick Schummer, Ina Stolze, Judith Weber ほか 5 名 - European Journal of Cancer 2019 被引用: 354

  19. Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review

    著者: , , , , , , , , , , , , , - European Journal of Cancer 2021 被引用: 191

  20. SOX2 in development and cancer biology

    著者: , , , , , - Seminars in Cancer Biology 2019 被引用: 389

  21. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

    著者: , , , , - Journal of Clinical Investigation 2023 被引用: 101

  22. The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

    著者: , , , - Vaccines 2016 被引用: 441

  23. Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images

    著者: , , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 280

  24. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Jacques Grob - Annals of Oncology 2017 被引用: 652